News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Starting treatment news

Show

From To
PEP
Nevirapine should not be used for PEP confirms US review

HIV-negative people appear to have a higher risk of side-effects when exposed to nevirapine, according to a review of case reports and toxicity reports from

Published
02 February 2004
By
Edwin J. Bernard
Changing treatment
Meta-analysis finds PI-based HAART better than NNRTI regimens in NRTI experienced

Protease inhibitor (PI)-based highly active antiretroviral therapy (HAART) regimens are superior to non-nucleoside reverse transcriptase inhibitor (NNRTI)-based triple combinations, according to a meta-analysis of 14

Published
30 January 2004
By
Michael Carter
Starting treatment
French HIV-2 cohort study: treat only when plasma viral load can be measured.

HIV–2 is a genetically distinct virus from HIV-1, the latter of which is by far the most common form of HIV worldwide. HIV-2 is found

Published
26 January 2004
By
Edwin J. Bernard
Starting treatment
HIV patients with severe immune damage have incomplete immune recovery - but does it matter?

HIV-positive individuals who started HAART when they have very severe immune damage may have impaired immune reconstitution, even if their CD4 cell count recovers enough

Published
06 January 2004
By
Michael Carter
Families and children
More evidence that earlier treatment provides greatest benefit for children with HIV

In HIV positive children, starting antiretroviral therapy at younger ages and before severe immune suppression occurs appears to promote better CD4 cell recovery, according to

Published
01 January 2004
By
Liz Highleyman
Starting treatment
Better clinical outcomes if HAART started before CD4 cell count falls below 200

Individuals who start HAART when their CD4 cell count is below 200 cells/mm3 are more likely to progress to AIDS or death than patients who

Published
15 December 2003
By
Michael Carter
Starting treatment
Landmark study shows why AZT/3TC/efavirenz now preferred as first-line HIV treatment

The combination of AZT, 3TC and efavirenz proved more durable than two initial HAART combinations composed of four drugs, and outclassed all combinations based on

Published
12 December 2003
By
Michael Carter
Starting treatment
Combining ARVs with treatment for tuberculosis

Combining antiretroviral drugs (nevirapine / efavirenz / protease inhibitors) with tuberculosis drugs, including rifampicin.

Published
10 April 2003
From
HIV & AIDS treatment in practice
Starting treatment
Nevirapine-based fixed-dose combination ARVs

This article describes the early use of nevirapine-based fixed dose antiretroviral combinations in low and middle-income settings.

Published
27 March 2003
From
HIV & AIDS treatment in practice
← Prev1...5152535455Next →

Filter by country